Up next

Autoplay

MIBG Therapy for Pheochromocytomas and Paragangliomas

2 Views • 07/02/23
Share
Embed
administrator
administrator
Subscribers
0

Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay